NCT02111941.

Trial name or title	A pilot study of the safety and immunogenicity of folate receptor alpha peptide‐loaded dendritic cell vaccination in patients with advanced stage epithelial ovarian cancer
Methods	Uncontrolled phase I
Participants	19 women with stage IIIC‐IV ovarian epithelial, fallopian tube, or primary peritoneal cavity cancer following surgery and chemotherapy
Interventions	Multi‐epitope folate receptor alpha‐loaded dendritic cell vaccine
Outcomes	Adverse events Survival Immune response
Starting date	April 2014
Contact information
Notes	Active not recruiting, October 2017